Skip to Content

Daniel Gomez, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2004 University of California, San Francisco, CA, MD, Medical School
1999 University of Virginia, Charlottesville, VA, BA, Economics

Postgraduate Training

7/2005-12/2008 Clinical Residency, Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY
7/2004-6/2005 Medicine Internship, St. Mary's Medical Center, San Francisco, CA

Board Certifications

6/2010 Radiation Oncology


Institutional Committee Activities

Member, Institutional Committee on Radiation Policy for Implanted Cardiac Devices, 2012-2013
Member, MDACC Global Programs Committee, 2011-present
Member, Clinical Research Committee, 2011-2012
Head, Thoracic Radiation Oncology Education Committee, 6/2010-present
Member, Sister Network Institutional Funding Review Committee, 2010-present

Honors and Awards

2011-2013 Comparative Effectiveness Research on Cancer in Texas Scholar
2009-present Recipient, National Institutes of Health Loan Repayment Program
2009 Radiologic Society of North America Resident/Fellow Research Award
2002-2003 Doris Duke Clinical Research Fellowship Recipient
2001-2002 Gregory Scholarship Recipient
2001-2002 Mackenzie Scholarship Recipient
1999-present Duncan Clarke Hyde Award for Exceptional Academic Performance in Economics, Duncan Clarke
1999-2004 Bernard J. Osher Scholarship Recipient

Professional Memberships

American Medical Society
Member, 2010-present
American Radiologic Society
Member, 2010-present
American Radium Society
Member, 9/2009-12/2012
American Society for Therapeutic Radiology and Oncology ASTRO
Member, 9/2009-present
American Society of Clinical Oncology
Member, 2010-present
Gilbert Fletcher Society
Member, 2011-present
Harris County Medical Society
Member, 8/2009-present
International Association for the Study of Lung Cancer
Member, 1/2010-present
International Thymic Malignancy Interest Group
Member, 2010-present
Radiological Society of North America RSNA
Member, 1/2010-12/2011
Texas Medical Society
member, 2010-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Evans J, Gomez D, Chang J, Gladish G, Erasmus J, Rebueno N, Banchs J, Komaki R, Welsh J. Cardiac 18F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy. Radiother Oncol. In Press.
2. Ashworth AB, Senan S, Palma DA, Riquet M, Ahn YC, Ricardi U, Congedo MT, Gomez DR, Wright GM, Melloni G, Milano MT, Sole CV, De Pas TM, Carter DL, Warner AJ, Rodrigues GB. An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small-Cell Lung Cancer. Clin Lung Cancer 15(5):346-55, 9/2014. e-Pub 5/2014. PMID: 24894943.
3. Wen J, Liu H, Wang Q, Liu Z, Li Y, Xiong H, Xu T, Li P, Wang LE, Gomez DR, Mohan R, Komaki R, Liao Z, Wei Q. Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. Eur J Cancer 50(10):1706-16, 7/2014. e-Pub 4/2014. PMCID: PMC4155498.
4. Tang C, Liao Z, Zhuang Y, Levy LB, Hung C, Li X, Krafft SP, Martel MK, Komaki R, Gomez DR. Acute phase response before treatment predicts radiation esophagitis in non-small cell lung cancer. Radiother Oncol 110(3):493-8, 3/2014. e-Pub 2/20/2014. PMID: 24560756.
5. Rimner A, Gomez DR, Wu AJ, Shi W, Yorke ED, Moreira AL, Rice D, Komaki R, Rosenzweig KE, Riely GJ, Huang J. Failure patterns relative to radiation treatment fields for stage II-IV thymoma. J Thorac Oncol 9(3):403-9, 3/2014. PMID: 24518091.
6. Tang C, Gomez DR, Wang H, Levy LB, Zhuang Y, Xu T, Nguyen Q, Komaki R, Liao Z. Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 88(2):319-25, 2/1/2014. PMID: 24411603.
7. Gomez DR, Gladish GW, Wei X, Kotamarti KR, Allen PK, Cox JD, O'Reilly MS, Erasmus JJ, Fossella FV, Komaki R. Prognostic value of positron emission tomography/computed tomography findings in limited-stage small cell lung cancer. Am J Clin Oncol 37(1):77-80, 2/2014. PMID: 23111360.
8. Zhu Z, Liu W, Gillin M, Gomez DR, Komaki R, Cox JD, Mohan R, Chang JY. Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: A secondary analysis of a phase II trial. Radiat Oncol 9:108, 2014. e-Pub 5/6/2014. PMCID: PMC4029832.
9. Wang H, Liao Z, Zhuang Y, Xu T, Nguyen QN, Levy LB, O'Reilly M, Gold KA, Gomez DR. Do Angiotensin-Converting Enzyme Inhibitors Reduce the Risk of Symptomatic Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer After Definitive Radiation Therapy? Analysis of a Single-Institution Database. Int J Radiat Oncol Biol Phys 87(5):1071-7, 12/2013. e-Pub 10/2013. PMID: 24161424.
10. Shirvani SM, Jiang J, Gomez DR, Chang JY, Buchholz TA, Smith BD. Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: Predictors of use and association with toxicities. Lung Cancer 82(2):252-9, 11/2013. e-Pub 8/21/2013. PMCID: PMC3839043.
11. Gomez DR, Poenisch F, Pinnix CC, Sheu T, Chang JY, Memon N, Mohan R, Rozner MA, Dougherty AH. Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors. Int J Radiat Oncol Biol Phys 87(3):570-5, 11/2013. PMID: 24074931.
12. McAvoy SA, Ciura KT, Rineer JM, Allen PK, Liao Z, Chang JY, Palmer MB, Cox JD, Komaki R, Gomez DR. Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer. Radiother Oncol 109(1):38-44, 10/2013. e-Pub 9/7/2013. PMID: 24016675.
13. Shirvani SM, Juloori A, Allen PK, Komaki R, Liao Z, Gomez D, O'Reilly M, Welsh J, Papadimitrakopoulou V, Cox JD, Chang JY. Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer. Int J Radiat Oncol Biol Phys 87(1):139-47, 9/2013. PMID: 23920393.
14. Chang JY, Liu YH, Zhu Z, Welsh JW, Gomez DR, Komaki R, Roth JA, Swisher SG. Stereotactic Ablative Radiotherapy: A Potentially Curable Approach to Early-Stage Multiple Primary Lung Cancer. Cancer 119(18):3402-10, 9/2013. e-Pub 6/2013. PMCID: PMC3775964.
15. Gomez DR, Gillin M, Liao Z, Wei C, Lin SH, Swanick C, Alvarado T, Komaki R, Cox JD, Chang JY. Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 86(4):665-70, 7/2013. e-Pub 5/2013. PMID: 23688815.
16. Gomez D, Tsao A, Rice D. Recurrence of malignant pleural mesothelioma at the resection borders--local or distant recurrence? J Thorac Oncol 8(7):e65-6, 7/2013. PMID: 23774390.
17. Wang HM, Liao ZX, Komaki R, Welsh JW, O'Reilly MS, Chang JY, Zhuang Y, Levy LB, Lu C, Gomez DR. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small cell lung cancer treated with definitive radiation therapy. Ann Oncol 24(5):1312-9, 5/2013. e-Pub 1/2013. PMCID: PMC3629895.
18. Pang Q, Wei Q, Xu T, Yuan X, Lopez Guerra JL, Levy LB, Liu Z, Gomez DR, Zhuang Y, Wang LE, Mohan R, Komaki R, Liao Z. Functional Promoter Variant rs2868371 of HSPB1 Is Associated With Risk of Radiation Pneumonitis After Chemoradiation for Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 85(5):1332-9, 4/2013. e-Pub 1/2013. PMID: 23374503.
19. Xiong H, Liao Z, Liu Z, Xu T, Wang Q, Liu H, Komaki R, Gomez D, Wang LE, Wei Q. ATM Polymorphisms Predict Severe Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy. Int J Radiat Oncol Biol Phys 85(4):1066-73, 3/2013. e-Pub 11/2012. PMCID: PMC3594431.
20. Zelefsky MJ, Gomez DR, Polkinghorn WR, Pei X, Kollmeier M. Biochemical Response to Androgen Deprivation Therapy Before External Beam Radiation Therapy Predicts Long-Term Prostate Cancer Survival Outcomes. Int J Radiat Oncol Biol Phys. e-Pub 3/2013. PMID: 23523323.
21. Evans JD, Gomez DR, Amini A, Rebueno N, Allen PK, Martel MK, Rineer JM, Ang KK, McAvoy S, Cox JD, Komaki R, Welsh JW. Aortic dose constraints when reirradiating thoracic tumors. Radiother Oncol. e-Pub 2/2013. PMID: 23453540.
22. Gomez DR, Hong DS, Allen PK, Welsh JS, Mehran RJ, Tsao AS, Liao Z, Bilton SD, Komaki R, Rice DC. Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. J Thorac Oncol 8(2):238-45, 2/2013. PMID: 23247629.
23. Lopez Guerra JL, Gomez DR, Lin SH, Levy LB, Zhuang Y, Komaki R, Jaen J, Vaporciyan AA, Swisher SG, Cox JD, Liao Z, Rice DC. Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy. Ann Oncol 24(1):67-74, 1/2013. e-Pub 9/2012. PMCID: PMC3525136.
24. Court LE, Tucker SL, Gomez D, Liao Z, Zhang J, Kry S, Dong L, Martel MK. A technique to use CT images for in vivo detection and quantification of the spatial distribution of radiation-induced esophagitis. J Appl Clin Med Phys 14(3):4195, 2013. e-Pub 5/2013. PMID: 23652249.
25. Niedzielski J, Bluett JB, Williamson RT, Liao Z, Gomez DR, Court LE. Analysis of esophageal-sparing treatment plans for patients with high-grade esophagitis. J Appl Clin Med Phys 14(4):4248, 2013. e-Pub 7/8/2013. PMID: 23835390.
26. Gomez DR, Liao KP, Giordano S, Nguyen H, Smith BD, Elting LS. Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: a population-based study. Cancer. e-Pub 12/2012. PMID: 23212885.
27. Guerra JL, Gomez D, Wei Q, Liu Z, Wang LE, Yuan X, Zhuang Y, Komaki R, Liao Z. Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer. Radiother Oncol 105(3):299-304, 12/2012. e-Pub 9/2012. PMID: 23022171.
28. Shirvani SM, Jiang J, Chang JY, Welsh JW, Gomez DR, Swisher S, Buchholz TA, Smith BD. Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly. Int J Radiat Oncol Biol Phys. e-Pub 9/2012. PMID: 22975611.
29. Lopez Guerra JL, Gomez D, Zhuang Y, Hong DS, Heymach JV, Swisher SG, Lin SH, Komaki R, Cox JD, Liao Z. Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis. Int J Radiat Oncol Biol Phys 84(1):e61-7, 9/2012. e-Pub 4/2012. PMID: 22503522.
30. Gomez DR, Tucker SL, Martel MK, Mohan R, Balter PA, Lopez Guerra JL, Liu H, Komaki R, Cox JD, Liao Z. Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. e-Pub 8/21/2012. PMID: 22920974.
31. Lopez Guerra JL, Gomez D, Zhuang Y, Levy LB, Eapen G, Liu H, Mohan R, Komaki R, Cox JD, Liao Z. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 83(5):1573-9, 8/2012. PMID: 22768989.
32. Lopez Guerra JL, Gomez DR, Zhuang Y, Levy LB, Eapen G, Liu H, Mohan R, Komaki R, Cox JD, Liao Z. Changes in Pulmonary Function after Three-Dimensional Conformal Radiotherapy, Intensity-Modulated Radiotherapy, or Proton Beam Therapy for Non-Small-Cell Lung Cancer. Int J Radiat Oncol Biol Phys 83(4):e537-43, 7/2012. e-Pub 3/2012. PMID: 22420964.
33. Amini A, Yang J, Williamson R, McBurney ML, Erasmus J, Allen PK, Karhade M, Komaki R, Liao Z, Gomez D, Cox J, Dong L, Welsh J. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. Int J Radiat Oncol Biol Phys 82(3):e391-8, 3/2012. PMID: 22284035.
34. Lopez Guerra JL, Gladish G, Komaki R, Gomez D, Zhuang Y, Liao Z. Large decreases in standardized uptake values after definitive radiation are associated with better survival of patients with locally advanced non-small cell lung cancer. J Nucl Med 53(2):225-33, 2/2012. e-Pub 1/2012. PMID: 22241911.
35. Gomez DR, Cox JD, Roth JA, Allen PK, Wei X, Mehran RJ, Kim JY, Swisher SG, Rice DC, Komaki R. A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumors. Cancer 118(2):444-451, 2012. e-Pub 6/2011. PMID: 21713767.
36. Jiang ZQ, Yang K, Komaki R, Wei X, Tucker SL, Zhuang Y, Martel MK, Vedam S, Balter P, Zhu G, Gomez D, Lu C, Mohan R, Cox JD, Liao Z. Long-Term Clinical Outcome of Intensity-Modulated Radiotherapy for Inoperable Non-Small-Cell Lung Cancer: The MD Anderson Experience. Int J Radiat Oncol Biol Phys. e-Pub 11/2011. PMID: 22079735.
37. Lopez Guerra JL, Wei Q, Yuan X, Gomez D, Liu Z, Zhuang Y, Yin M, Li M, Wang LE, Cox JD, Liao Z. Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy. Radiother Oncol. e-Pub 9/2011. PMID: 21937138.
38. Yin M, Liao Z, Liu Z, Wang LE, O'Reilly M, Gomez D, Li M, Komaki R, Wei Q. Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy. Cancer. e-Pub 6/2011. PMID: 21717429.
39. Chi A, Liao Z, Nguyen NP, Howe C, Gomez D, Jang SY, Komaki R. Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined-Modality Treatment of Malignant Pleural Mesothelioma. J Thorac Oncol 6(6):1132-41, 6/2011. e-Pub 4/2011. PMID: 21532502.
40. Gomez DR, Estilo CL, Wolden SL, Zelefsky MJ, Kraus DH, Wong RJ, Shaha AR, Shah JP, Mechalakos JG, Lee NY. Correlation of Osteoradionecrosis and Dental Events with Dosimetric Parameters in Intensity-Modulated Radiation Therapy for Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys. e-Pub 5/2011. PMID: 21570202.
41. Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, Zhu XR, Likhacheva A, Liao Z, Hofstetter WL, Ajani JA, Cox JD. Intensity-modulated proton therapy further reduces normal- tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study. Int J Radiat Oncol Biol Phys. e-Pub 4/2011. PMID: 21470796.
42. Yin M, Liao Z, Huang YJ, Liu Z, Yuan X, Gomez D, Wang LE, Wei Q. Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy. PLoS One 6(5):e20055, 2011. e-Pub 5/2011. PMCID: PMC3102071.
43. Guan X, Liao Z, Ma H, Qian J, Liu Z, Yuan X, Gomez D, Komaki R, Wang LE, Wei Q. TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy. BMC Cancer 11:447, 2011. e-Pub 10/2011. PMCID: PMC3220654.
44. Welsh J, Palmer MB, Ajani JA, Liao Z, Swisher SG, Hofstetter WL, Allen PK, Settle SH, Gomez D, Likhacheva A, Cox JD, Komaki R. Esophageal cancer dose escalation using a simultaneous integrated boost technique. Int J Radiat Oncol Biol Phys. e-Pub 11/2010. PMID: 21123005.
45. Wu AJ, Gomez J, Zhung JE, Chan K, Gomez DR, Wolden SL, Zelefsky MJ, Wolchok JD, Carvajal RD, Chapman PB, Wong RJ, Shaha AR, Kraus DH, Shah JP, Lee NY. Radiotherapy after surgical resection for head and neck mucosal melanoma. Am J Clin Oncol 33(3):281-5, 6/2010. PMID: 19823070.
46. Gomez D, Cahlon O, Mechalakos J, Lee N. An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer. Radiat Oncol 5:74, 2010. e-Pub 8/2010. PMCID: PMC2940770.
47. Gomez DR, Hunt MA, Jackson A, O'Meara WP, Bukanova EN, Zelefsky MJ, Yamada Y, Rosenzweig KE. Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy. Radiother Oncol 93(3):414-8, 12/2009. e-Pub 11/2009. PMCID: PMC2858382.
48. Gomez DR, Katabi N, Zhung J, Wolden SL, Zelefsky MJ, Kraus DH, Shah JP, Wong RJ, Ghossein RA, Lee NY. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer 115(10):2128-37, 5/2009. PMID: 19309749.
49. Gomez DR, Zhung JE, Gomez J, Chan K, Wu AJ, Wolden SL, Pfister DG, Shaha A, Shah JP, Kraus DH, Wong RJ, Lee NY. Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys 73(4). e-Pub 8/2008. PMID: 18707827.
50. Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer 113(1):48-56, 7/2008. PMID: 18484584.
51. Gomez DR, Hoppe BS, Wolden SL, Zhung JE, Patel SG, Kraus DH, Shah JP, Ghossein RA, Lee NY. Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. Int J Radiat Oncol Biol Phys 70(5):1365-72, 4/2008. e-Pub 10/2007. PMID: 18029108.
52. Hoppe BS, Nelson CJ, Gomez DR, Stegman LD, Wu AJ, Wolden SL, Pfister DG, Zelefsky MJ, Shah JP, Kraus DH, Lee NY. Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys 72(3). e-Pub 4/2008. PMID: 18395361.
53. Gomez DR, Missett BT, Wara WM, Lamborn KR, Prados MD, Chang S, Berger MS, Haas-Kogan DA. High failure rate in spinal ependymomas with long-term follow-up. Neuro Oncol 7(3):254-9, 7/2005. PMCID: PMC1871913.

Invited Articles

1. Wang H, Gomez DR, Liao Z. β-blockers and metastasis in non-small-cell lung cancer. Expert Rev Anticancer Ther 13(6):641-3, 6/2013. PMID: 23773098.
2. Wang H, Gomez D, Liao Z. Could B-blockers be a feasible treatment option for lung cancer? A review of the current literature. Lung Cancer Management 2(4):247-9, 2013.
3. Gomez D, Niibe Y, Chang J. Oligometastic disease at presentation or recurrence for NSCLC. Pulm Med, 7/2012.
4. Gomez DR. Postoperative radiation therapy for non-small cell lung cancer and thymic malignancies. Cancers, 3/2012.
5. Gomez D, Komaki R, Yu J, Ikushima H, Bezjak A. Radiation Therapy Definitions and Reporting Guidelines for Thymic Malignancies. J Thorac Oncol 6(7 Suppl 3):S1743-S1748, 7/2011. PMID: 21847057.
6. Welsh J, Amini A, Likhacheva A, Erasmus J J, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee H J, Bhutani MS, Ajani JA. Modern Approaches to the Treatment of Localized Esophageal Cancer. Curr Oncol Rep 13(3):67, 6/2011. PMID: 21365188.
7. Gomez DR, Chang JY. Adaptive Radiation for Lung Cancer. J Oncol 2011, 2011. e-Pub 8/2010. PMCID: PMC2931378.
8. Gomez D, Komaki R. Technical advances of radiation therapy for thymic malignancies. J Thorac Oncol 5(10 Suppl 4):S336-43, 10/2010. e-Pub 10/2010. PMID: 20859129.

Book Chapters

1. Gomez D, Liao Z. Target Delineation for Non-Small Cell Lung Cancer. In: Target Volume Delineation and Treatment Planning for Conformal Radiation Therapy (IMRT). In Press.
2. Saintigny P, Gomez D, Liao Z, Komaki R. Combinations of radiation therapy and chemotherapy for NSCLC and SCLC. In: Lung Cancer, 2013.
3. David E, Gomez DR, Komaki R, Walsh G. Staging and Prognosis. In: Personalized Management of Lung Cancer. Future Medicine Ltd, e-Book 2013.
4. Gomez D, Fuller C, Chennupati S, Thomas C. Mediastinal and Tracheal Tumors. In: Principles and Practices of Radiation Oncology, 6th. Lippincott Williams and Wilkins, 2012.
5. Gomez D, Jeter M, Komaki R, Cox J. Radiation Time, Dose and Fractionation in the Treatment of Lung Cancer. In: Advances in Radiation Oncology of Lung Cancer, 2nd. Springer Verlag Publishers, 2012.
6. Gomez D, Liao Z. Radiation Toxicity in the Treatment of Lung Cancer with 3D-Conformal Therapy, Intensity Modulated Radiation Therapy, and Proton Beam Therapy. In: Radiation Therapy: Types, Procedures and Outcomes. Nova Science Publishers, 2012.
7. Troung MT, Gomez D, Chang JY, Mehran RJ. Oncologic imaging for the practicing radiologist. In: Medical Oncologist and Surgeon. Elsevier Publishing, 2011.
8. Gomez D, Lee N. Oral Cavity Cancer. In: Textbook of Radiation Oncology. WB Saunders Publishing, 2009.
9. Gomez D, Chao K, Lee N. Target Delineation in Head and Neck Cancer. In: Image Guided and Adaptive Radiotherapy. Lippincott Williams & Wilkins Publishing, 2009.

Grant & Contract Support

Title: Molecular Alterations Associated with Chemoresistance and Recurrence in Oligometastic NSCLC
Funding Source: University of Texas
Role: Principal Investigator
Duration: 2/2013 - 1/1/2014
Title: Phase II Toxicity Study Using Chemotherapy +/- Pleurectomy/Decortication Followed by Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Malignant Pleural Mesothelioma
Funding Source: Memorial Sloan Kettering
Role: Co-Investigator
Duration: 1/1/2012 - 1/1/2014

Last updated: 7/24/2015